Data Updates in GI Cancers and HCC from ESMO 2024 - Episode 5
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on trastuzumab deruxtecan–based regimens in advanced HER2-positive GI cancers.
Related Content: